ONXX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Onyx Pharmaceuticals, Inc.'s diluted earnings per share (Diluted EPS) for the three months ended in Jun. 2013 was $-0.73. Its diluted earnings per share (Diluted EPS) for the trailing twelve months (TTM) ended in Jun. 2013 was $-1.59.
Onyx Pharmaceuticals, Inc.'s basic earnings per share (Basic EPS) for the three months ended in Jun. 2013 was $-0.73. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Jun. 2013 was $-1.58.
Onyx Pharmaceuticals, Inc.'s earnings per share without non-recurring items for the three months ended in Jun. 2013 was $-0.73. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jun. 2013 was $-1.59.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using earnings per share (NRI) data.
EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.
Onyx Pharmaceuticals, Inc.'s Diluted EPS for the fiscal year that ended in Dec. 2012 is calculated as
|Diluted EPS (A: Dec. 2012 )||=||(Net Income||-||Preferred Dividends)||/||Total Shares Outstanding|
Onyx Pharmaceuticals, Inc.'s Diluted EPS for the quarter that ended in Jun. 2013 is calculated as
|Diluted EPS (Q: Jun. 2013 )||=||(Net Income||-||Preferred Dividends)||/||Total Shares Outstanding|
Onyx Pharmaceuticals, Inc. EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2013 was 0.25 (Sep. 2012 ) + -0.636 (Dec. 2012 ) + -0.47 (Mar. 2013 ) + -0.73 (Jun. 2013 ) = $-1.59
EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.
Compared with Earnings per share, a companys cash flow is better indicator of the companys earnings power.
If a companys earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Onyx Pharmaceuticals, Inc. Annual Data
Onyx Pharmaceuticals, Inc. Quarterly Data
Disclaimers: GuruFocus.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The gurus may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.